PetVivo Holdings to Present Veterinary Medical Innovations at Spartan Capital Investor Conference

PetVivo Holdings, Inc. will present at the Spartan Capital Securities Second Annual Investor Conference on November 3, 2025, at the Marriott Marquis Hotel in New York City. The company's participation signals growing investor interest in the veterinary biomedical sector and highlights innovative treatments for animal joint disorders that could reshape veterinary care standards.

Chief Executive Officer John Lai will provide an overview of PetVivo Holdings and discuss the company's flagship products, SPRYNG with OsteoCushion Technology and PrecisePRP. These veterinary medical devices represent significant advancements in managing joint pain and degenerative conditions in companion animals and equines, addressing a substantial market need for effective, convenient treatments.

SPRYNG with OsteoCushion Technology is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles. The technology works by having microparticles adsorb onto the joint synovial lining of animals and subsequently integrate with the animal's subsynovial tissue. This action promotes the restoration of proper joint mechanics, thereby aiding in the management of noninfectious sources of joint pain such as joint instability, degenerative joint disease and osteoarthritis.

PrecisePRP represents a breakthrough as a first-in-class off-the-shelf platelet-rich plasma product designed for veterinary use. Unlike traditional PRP mechanical kits that require blood draws and centrifugation, PrecisePRP offers a leucoreduced, allogeneic, pooled, freeze-dried PRP that provides a species-specific source of concentrated platelets for intra-articular administration in dogs and horses. Each vial contains a consistent dose of 4 billion platelets per vial at a concentration of 500,000 platelets per microliter and is leucoreduced with less than 1500 white blood cells per microliter.

The conference, organized in partnership with B2i Digital, will showcase more than 60 carefully selected companies across technology, healthcare, consumer, mining, precious metals, and other high-growth sectors. Over 500 institutional and high-net-worth investors are expected to attend, creating significant exposure opportunities for participating companies. For more information about the conference and registration details, please visit https://spartancapital.com.

John D. Lowry, Founder and Chief Executive Officer of Spartan Capital Securities, LLC, emphasized the conference's mission to connect growth companies with appropriate investors and resources. David Shapiro, CEO of B2i Digital, noted that PetVivo's participation aligns with their commitment to connecting investors with diverse growth companies, combining digital marketing reach with face-to-face investor engagement through platforms like https://b2idigital.com.

The event will feature main-stage presentations, expert panels, curated one-on-one meetings, and extensive networking sessions, creating meaningful opportunities for dialogue between growth companies and the investment community. PetVivo's presentation at this prestigious forum underscores the growing importance of veterinary medical innovation and signals potential expansion opportunities for companies developing animal healthcare solutions.